The ASAM Alcohol Withdrawal Management Webinar Series - Identification, Diagnosis, and Initial Assessment
Includes a Live Event on 08/24/2020 at 1:00 PM (EDT)
The ASAM Alcohol Withdrawal Management Webinar Series – Identification, Diagnosis, and Initial Assessment
The webinar follows the ASAM Alcohol Withdrawal Management Fundamentals webinar, which intends to aid clinicians in their clinical decision making and management of patients experiencing alcohol withdrawal syndrome, as written in The ASAM Clinical Practice Guideline on Alcohol Withdrawal Management.
Signs and symptoms of AWS can escalate quickly and the trajectory of alcohol withdrawal can vary considerably among patients. As the most severe presentations of alcohol withdrawal are life threatening, orienting the initial assessment toward evaluating risk is recommended. The second of its series, this webinar will provide an overview of the assessment recommendations around alcohol withdrawal management and in-depth information on tools and differential diagnosis.
Date: Monday, August 24, 2020
Time: 1:00 pm ET / 12:00 pm CT/ 10:00 am PT
Speaker(s): Kurt Kleinschmidt, MD and Dazhe Cao, MD
By completing this session, you will be able to:
- 1. Summarize the guideline’s treatment recommendations around assessment of alcohol withdrawal syndrome and discuss how they should be used in practice.
- 2. Recognize the risk assessment tools available to identify patients at risk of developing alcohol withdrawal.
- 3. Describe how to make appropriate differential diagnosis.
Kurt C. Kleinschmidt, MD, FACMT, FASAM is a Professor of Emergency Medicine at the University of Texas Southwestern Medical Center in Dallas, Texas. He is Chief of the Division of Medical Toxicology. His areas of interest include Substance Use Disorders and snake envenomations. He graduated from the University of South Florida College of Medicine in 1986, completed his emergency medicine residency at Madigan Army Medical Center in 1990, and finished a clinical fellowship in Medical Toxicology at the University of Texas Southwestern Medical Center in 1999. He is board certified in Emergency Medicine (1991), Medical Toxicology (2002), and Addiction Medicine (2015). He became the Medical Director of the Perinatal Intervention Program in Parkland Health and Hospital system in 2016. He served as the Toxicology Program Director from 2004-2018.
Dazhe (James) Cao
Dazhe (James) Cao, MD s an Assistant Professor in the Department of Emergency Medicine at UT Southwestern Medical Center.
Dr. Cao earned his medical degree at Baylor College of Medicine. He completed a residency in emergency medicine at Carolinas Medical Center and received advanced training in medical toxicology through a fellowship at Rocky Mountain Poison & Drug Safety.
Certified by the American Board of Emergency Medicine in emergency medicine and medical toxicology, he joined the UT Southwestern faculty in 2015.
Dr. Cao is Program Director of Medical Toxicology at UT Southwestern and Medical Director of Toxicology for the Parkland Health & Hospital System. He serves on the American College of Medical Toxicology’s Fellowship Directors committee.
In addition, he is a member of the American Academy of Clinical Toxicology, the American College of Emergency Physicians, and the Emergency Medicine Residents’ Association.
Dr. Cao has delivered numerous national and regional invited lectures, contributed to the seventh edition of the book Emergency Medicine Secrets, and published several academic articles.
ACCME Accreditation Statement
The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA Credit Designation Statement
The American Society of Addiction Medicine designates this internet live course for a maximum of 1 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
NAADAC, the Association for Addiction Professionals
This activity has been approved by the American Society of Addiction Medicine, as a NAADAC Approved Education Provider, for educational credits. NAADAC Provider #295, ASAM is responsible for all aspects of the programming.
California Association for Drug/Alcohol Educators (CAADE)
This educational program is approved by CAADE: #CP40 999 1222
California Association of DUI Treatment Centers (CADTP)
This educational program is approved by CADTP: #205
Continuing Education Credits (CEUs)
Non-physician participants will receive a certificate of attendance upon completion of the activity and an online evaluation confirming their participation. Participants should submit his/her certificate of attendance to their professional organization/institute.
Maintenance of Certification (MOC)
ABPM Maintenance of Certification (MOC)
The American Board of Preventive Medicine (ABPM) has approved this activity for a maximum of 1 LLSA credit towards ABPM MOC Part II requirements.
ABA Maintenance of Certification (MOC)
This activity contributes to the CME component of the American Board of Anesthesiology’s redesigned Maintenance of Certification in Anesthesiology TM (MOCA®) program, known as MOCA 2.0®.
ABP Maintenance of Certification (MOC)
Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn a maximum of 1 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.
ABIM Maintenance of Certification (MOC)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
ABAM Transitional Maintenance of Certification (Tmoc)
Successful completion of this activity can be used to satisfy the American Board of Addiction Medicine (ABAM) for Tmoc as credits towards ABAM LLSA Part II requirements.
American Board of Psychiatry and Neurology (ABPN)
Successful completion of this CME activity can be used to satisfy the American Board of Psychiatry and Neurology’s (ABPN) CME requirement for Maintenance of Certification program.
Program Planning Committee, CME Committee, Medical Education Council (MEC)
In accordance with disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME activities. These policies include resolving all possible conflicts of interest for the Planning Committees, CME Committee, MEC, and Faculty. All activity Planning Committee members and Faculty have disclosed relevant financial relationship information. The ASAM CME Committee has reviewed these disclosures and determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity.
ASAM CME Committee Reviewer
Ed Salsitz, MD, DFASAM - No Financial Disclosures
Faculty & Planning Committee Disclosures
Lewis S. Nelson, MD, FASAM (Chair) – No Relevant Financial Disclosures
Kurt Kleinschmidt, MD, FASAM – No Relevant Financial Disclosures
Gerald E. Marti, MD, PhD – No Relevant Financial Disclosures
Darius Rastegar, MD, FASAM – No Relevant Financial Disclosures
Dazhe Cao, MD – No Relevant Financial Disclosures
George Kolodner, MD, DLFAPA, FASAM – Does Disclose: Kolmac Outpatient Recovery Centers, Self, Employment, Ownership Interest (includes stock, stock options, patent or other intellectual property) Clinical Condition: Substance Use Disorder
Michael F. Weaver, MD, DFASAM – No Relevant Financial Disclosures